Progression To Insulin Dependence Post-Treatment With Immune Checkpoint Inhibitors In Pre-Existing Type 2 Diabetes

Progression To Insulin Dependence Post-Treatment With Immune Checkpoint Inhibitors In Pre-Existing Type 2 Diabetes

ABSTRACT: Objective: To present 2 cases in which patients previously diagnosed with type 2 diabetes (T2D) rapidly progressed to insulin dependence following cancer treatment with immune checkpoint inhibitors (ICH). Both patients were subsequently found to be positive for glutamic acid decarboxylase...

Full description

Bibliographic Details
Main Authors:	Lorena Alarcon-Casas Wright, MD, FACE, Rebeca Vargas Ramon, MD, Zona Batacchi, MD, Irl B. Hirsch, MD
Format:	Article
Language:	English
Published:	Elsevier 2017-01-01
Series:	AACE Clinical Case Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2376060520302030

Similar Items

Immune Checkpoint Inhibitors for the Therapy of Thymoma
by: Alicia Quilez, MD, et al.
Published: (2020-03-01)

Immune Checkpoint Inhibitor-Associated Myocarditis
by: Grigorios Chatzantonis, MD, et al.
Published: (2020-04-01)

Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma
by: Xinlun Dai MD, et al.
Published: (2020-08-01)

Hyperprogressive NSCLC With Two Immune-Checkpoint Inhibitors
by: Saro Kasparian, MD, et al.
Published: (2020-06-01)

Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab
by: Hideo Oishi, MD, et al.
Published: (2020-10-01)

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
by: Taylor C. Duke, MD, et al.
Published: (2020-12-01)

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
by: Osnat Itzhaki Ben Zadok, MD, MS, et al.
Published: (2019-09-01)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
by: Joshua E. Reuss, MD, et al.
Published: (2021-10-01)

Association of Immune-Mediated Cerebellitis With Immune Checkpoint Inhibitor Therapy
by: Joanna Zurko, MD, et al.
Published: (2018-03-01)

Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer
by: Lova Sun, MD, et al.
Published: (2019-12-01)

Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
by: Marka R. Crittenden, et al.
Published: (2018-05-01)

Primary Adrenal Insufficiency from Immune Checkpoint Inhibitors
by: Afreen Idris Shariff, MD, et al.
Published: (2018-05-01)

Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients
by: Johnny Chahine, MD, et al.
Published: (2020-02-01)

Cardiac Adverse Events Related to Immune Checkpoint Inhibitors∗
by: Dorothy M. Gujral, PhD, et al.
Published: (2020-02-01)

Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation
by: Jacinth J. Joseph, MD, et al.
Published: (2020-09-01)

Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC
by: Taichi Miyawaki, MD, et al.
Published: (2020-06-01)

Hyponatremia and Fever in a Patient on Ipilimumab and Nivolumab (Immune Checkpoint Inhibitors): A Case Report
by: Sumit S. Patel MD, et al.
Published: (2021-09-01)

Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
by: Ander Mayor Ibarguren, MD, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
by: Kalyan R. Chitturi, DO, et al.
Published: (2019-12-01)

Gender Differences in the Incidence of Adverse Cardiovascular Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Sheharyar Minhas, MD, et al.
Published: (2020-09-01)

Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma
by: Fan-li Zeng MD, et al.
Published: (2021-09-01)

Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker
by: Karima Oualla MD, et al.
Published: (2021-04-01)

Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients
by: Mandar A. Aras, MD, PhD, et al.
Published: (2020-09-01)

658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases
by: Jeffrey Weber, et al.
Published: (2020-11-01)

Plasma Exchange for Immune Checkpoint Inhibitor–Induced MyocarditisNovel Teaching Points
by: Haran Yogasundaram, MD, et al.
Published: (2021-03-01)

Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy
by: Ajit Venniyoor
Published: (2019-01-01)

Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
by: Roger Y. Kim, MD, et al.
Published: (2021-06-01)

Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
by: Omar M. El Kawkgi, MB, BCh, BAO, et al.
Published: (2020-12-01)

Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors
by: Mariana Mirabel, MD, PhD, et al.
Published: (2020-09-01)

Addition of Dulaglutide for a High-Dose Insulin Requiring Patient with Type 2 Diabetes Mellitus: A Remarkable Response
by: Mehrunissa Kazim, MD, et al.
Published: (2019-03-01)

Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota
by: Arthur E. Frankel MD, et al.
Published: (2019-04-01)

Research Progress of Immune Checkpoint Inhibitors in Colorectal Cancer
by: ZHUANG Yuwen, et al.
Published: (2020-07-01)

Immune checkpoint inhibitors: recent progress and potential biomarkers
by: Pramod Darvin, et al.
Published: (2018-12-01)

Research Progress of Intestinal Microbiota and Immune Checkpoint Inhibitors
by: DAN Huimin, et al.
Published: (2019-11-01)

Progress of Steroids Effect on Efficacy of Immune Checkpoint Inhibitors
by: Guoqiang PAN, et al.
Published: (2019-12-01)

Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis
by: Yunwei LIU, et al.
Published: (2021-09-01)

Proton Pump Inhibitor–induced Hyperhidrosis: Important but Not Recognized
by: David A. Baidal, MD, et al.
Published: (2016-01-01)

Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients
by: Song Y. Park, MD, et al.
Published: (2021-02-01)

Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event
by: Jolanta Pach, BA, et al.
Published: (2021-07-01)

Pre-Existing Cardiovascular Conditions as Clinical Predictors of Myocarditis Reporting with Immune Checkpoint Inhibitors: A VigiBase Study
by: Roberta Noseda, et al.
Published: (2020-11-01)

Cannot write session to /tmp/vufind_sessions/sess_ebrju7k0ik4j2b43gpqpp68bcf